Biological vs. Psychological Treatments of Anxiety Disorders
In my other chapter in this book (Biological vs. Psychological Perspectives on Anxiety Disorder) I presented a Table 1 listing some proposed etiologies of anxiety disorders and corresponding treatments. It would be wrong to infer from this table that the postulated causes were discovered first and the treatments followed as logical deductions. In many cases, a cause was inferred from the presumed mechanism of action of some treatment believed to be effective against anxiety. Treatments of mental disorders have always seemed more rooted in reality than theories of mental disorders. It is instructive, therefore, to examine outcome studies of purportedly successful biological and psychological treatments of anxiety disorders in order to determine how solid the factual bases of those inferences really are.
Unable to display preview. Download preview PDF.
- Agras, W.S., Teich, M.J., Taylor, C.B., Roth, W.T., and Brouillard, M.E. (1990). Imipramine and exposure therapy in agoraphobia: Untangling the actions and interactions. Submitted for publication.Google Scholar
- Ballenger, J.C., Burrows, G.D., DuPont, R.L., Lesser, I.M., Noyes, R, Jr., Pecknold, J.C, Rifkin, A., and Swinson, R.P. (1988). Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial. I. Efficacy in short-term treatment. Archives of General Psychiatry, 45, 413–422.PubMedCrossRefGoogle Scholar
- Fiegenbaum, W. (1988). Long-term efficacy of ungraded versus graded massed exposure in agoraphobics. In I. Hand and H.-U. Wittchen (Eds.), Panic and Phobias 2. Treatments and Variables affecting Course and Outcome (pp. 83–88). Berlin: Springer-Verlag.Google Scholar
- Fisher, S., and Greenberg, R.P. (1989). A second opinion: Rethinking the claims of biological psychiatry. In S. Fisher and R.P. Greenberg (Eds.), The Limits of Biological Treatments for Psychological Distress. Comparisons with Psychotherapy and Placebo (pp. 309–336). Hillsdale, NJ: Erlbaum.Google Scholar
- Frank, J.D. (1961). Persuasion and Healing. A Comparative Study of Psychotherapy. Baltimore: Johns Hopkins Press.Google Scholar
- Greenberg, R.P, and Fisher, S. (1989). Examining antidepressant effectiveness: Findings, ambiguities, and some vexing puzzles. In S. Fisher and R.P. Greenberg (Eds.), The Limits of Biological Treatments for Psychological Distress. Comparisons with Psychotherapy and Placebo (pp. 1–37). Hillsdale, NJ: Erlbaum.Google Scholar
- Margraf, J. (1989). Beiträge zur Diagnostik, Theorie und Therapie des Paniksyndroms. Habilitationsschrift, Fachbereich Psychologie der Philipps-Universität Marburg. Submitted 1989.Google Scholar
- Marks, I.M. (1987). Fears, Phobias, and Rituals. Panic, Anxiety, and Their Disorders. Oxford: Oxford University Press.Google Scholar
- Marks, I.M., De Albuquerque, A., Cottraux, J., Gentil, V., Greist, J., Hand, L, Liberman, R.L., Relvas, J.S., Tobena, A., Tyrer, P, and Wittchen, H.-U. (1989). The ‘efficacy’ of alprazolam in panic disorder and agoraphobia: A critique of recent reports. Letter to the Editor. Archives of General Psychiatry, 46, 668–670.PubMedCrossRefGoogle Scholar
- Mavissakalian, M. (1988). The mutually potentiating effects of imipramine and exposure in agoraphobia. In I. Hand, and H.-U. Wittchen. Panic and Phobias 2. Treatments and Variables affecting Course and Outcome (pp. 36–43). Berlin: Springer-Verlag.Google Scholar
- Mavissakalian, M., and Michelson, L. (1986). Relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine. Journal of Clinical Psychiatry, 143, 1106–1112.Google Scholar
- Overton, D.A. (1966). State-dependent learning produced by depressant and atropine-like drugs. Psychopharmacologia, 23, 373–385.Google Scholar